InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,061.82
(
-1.20%
)
US TECH 100
17,242.40
(
0.00%
)
Dow Jones
37,735.11
(
-0.65%
)
Brent Oil
89.90
(
0.02%
)
Bitcoin
63,272.21
(
-0.24%
)
Post# of 30990
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

knuts4oe

Send PM Follow Ignore
Followers 4
Posts 682
Boards Moderated 0
Alias Born 06/26/2013

knuts4oe

Re: MineAllMine post# 28251

Tuesday, 06/27/2017 9:44:08 AM

Tuesday, June 27, 2017 9:44:08 AM

Post# of 30990
What's wrong with my solution, where the Nilvad Phaze 3 results indicate that Nilvadipine demonstrated some degree of success in interrupting, for THE FIRST TIME IN HISTORY, the progression of Alzheimer's.

That would result in a huge demand for Nilvadipine to treat Alzheimer's, which Archer/Roskamp could license w/royalty. Roskamp could then spinoff Archer, Rock Creek re-emerges as a Delaware corporation, and Archer and Rock Creek merge as equals.

No bidding! No outsiders! Everybody is happy!
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up